Evidence map›Paper›PMID 32644266›Full record

ArticleJournal of medical virology2021

Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.

Hai-Bin Yu, Wen-Jing Wang, Shan Tang, De-Xi Chen, Bin Xu

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hai-Bin YuDepartment Three of Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Wen-Jing WangBeijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Shan TangDepartment Three of Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
De-Xi ChenBeijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Bin XuDepartment Two of Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-2123-7790
Capital Medical University · CN

Funding

Key Programs of Beijing Municipal Education Commission of China KZ202010025037
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 emerged in China in December 2019 and then rapidly spread worldwide. Why COVID-19 patients with the same clinical condition have different outcomes remains unclear. This study aimed to examine the differences in the phenotype and functions of major populations of immune cells between COVID-19 patients with same severity but different outcomes. Four common type adult inpatients with laboratory confirmed COVID-19 from Beijing YouAn Hospital, Capital Medical University were included in this study. The patients were divided into two groups based on whether or not COVID-19 polymerase chain reaction (PCR)-negative conversion occurred within 3 weeks. Peripheral blood samples were collected to compare the differences in the phenotype and functions of major populations of immune cells between the two groups of patients. The result shows that the proportions of CD3

Indexed as

Biological Variation, IndividualAdultAgedAntigens, CDCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCOVID-19COVID-19 TestingFemaleGene ExpressionHLA-DR AntigensHumansImmunity, InnateImmunophenotypingLymphocyte CountMaleAntigens, CDHLA-DR AntigensCOVID-19immune responsenucleic acid conversion

Identifiers

PMID32644266
PMCPMC7361346
OpenAlexW3040848352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.